Status and phase
Conditions
Treatments
Study type
Funder types
Identifiers
About
The TRIUMPH study is a randomized, double-blinded, 3-arm, parallel-group trial designed to compare the effects of anticholinergic bladder therapy versus a) beta-3-adrenergic agonist bladder therapy and b) no bladder pharmacotherapy on cognitive, urinary, and other aging-related functional outcomes in ambulatory older women with urgency-predominant urinary incontinence and either normal or mildly impaired cognitive function at baseline.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
270 participants in 3 patient groups, including a placebo group
Loading...
Central trial contact
Alison Huang, MD, MAS, MPhil; Ann Chang
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal